Puma Biotechnology, Inc. (PBYI)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 240.55M |
| Enterprise value | 256.10M |
| Trailing P/E | 11.09 |
| Forward P/E | 9.60 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.01 |
| Price/book (mrq) | 4.50 |
| Enterprise value/revenue | 1.09 |
| Enterprise value/EBITDA | 5.39 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.31 |
| 52-week change 3 | 79.50% |
| S&P500 52-week change 3 | 21.23% |
| 52-week high 3 | 7.7300 |
| 52-week low 3 | 2.1300 |
| 50-day moving average 3 | 5.6624 |
| 200-day moving average 3 | 4.1197 |
Share statistics
| Avg vol (3-month) 3 | 584.51k |
| Avg vol (10-day) 3 | 310.83k |
| Shares outstanding 5 | 48.21M |
| Implied shares outstanding 6 | 48.21M |
| Float 8 | 29.4M |
| % held by insiders 1 | 15.12% |
| % held by institutions 1 | 66.96% |
| Shares short (28 Mar 2024) 4 | 3.29M |
| Short ratio (28 Mar 2024) 4 | 4.41 |
| Short % of float (28 Mar 2024) 4 | 8.01% |
| Short % of shares outstanding (28 Mar 2024) 4 | 6.83% |
| Shares short (prior month 29 Feb 2024) 4 | 4.09M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 9.16% |
| Operating margin (ttm) | 21.37% |
Management effectiveness
| Return on assets (ttm) | 9.19% |
| Return on equity (ttm) | 57.54% |
Income statement
| Revenue (ttm) | 235.64M |
| Revenue per share (ttm) | 5.00 |
| Quarterly revenue growth (yoy) | 9.90% |
| Gross profit (ttm) | N/A |
| EBITDA | 44.78M |
| Net income avi to common (ttm) | 21.59M |
| Diluted EPS (ttm) | 0.4500 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 95.94M |
| Total cash per share (mrq) | 1.99 |
| Total debt (mrq) | 111.49M |
| Total debt/equity (mrq) | 208.62% |
| Current ratio (mrq) | 1.57 |
| Book value per share (mrq) | 1.12 |
Cash flow statement
| Operating cash flow (ttm) | 27.01M |
| Levered free cash flow (ttm) | 1.79M |
© 2024 Yahoo. All rights reserved.